Equity [Text Block] | NOTE 13: CAPITAL STOCK Equity Financing On May 17, 2021, 3 1933, June 1, 2021, “2021 “May 2021 2021 On May 14, 2021, “2021 “2021 2021 may, 2021 On November 26, 2021, 2021 May 2021 2021 may, 2021 “November 2021 May 2021 “2021 On November 16, 2022, 3 “2022 “2022 2021 2022 On November 16, 2022, “2022 “2022 2022 may, 2022 During the three nine April 30, 2023, nil 2021 nil During the three nine April 30, 2023, 2022 Share Purchase Warrants A continuity schedule of our outstanding share purchase warrants for the three nine April 30, 2023, Number of Warrants Weighted Average Exercise Price Balance, July 31, 2022 3,615,454 $ 1.92 Issuance of Replacement Warrants (Note 3,13) 4,660,580 2.84 Exercised (3,410,898 ) 1.80 Expired (27,550 ) 1.80 Balance, October 31, 2022 4,837,586 2.85 Exercised (45,000 ) 1.46 Balance, January 31, 2023 4,792,586 2.93 Balance, April 30, 2023 4,792,586 $ 2.88 A summary of our share purchase warrants outstanding and exercisable as of April 30, 2023, Weighted Average Exercise Price Number of Warrants Outstanding Weighted Average Remaining Contractual Life (Years) Expiry Date $ 1.72 144,194 0.05 May 20, 2023 1.64 25,000 0.06 May 21, 2023 1.43 766,362 0.09 June 2, 2023 3.17 3,675,212 1.36 September 7, 2024 4.13 181,818 2.93 April 5, 2026 $ 2.88 4,792,586 1.17 As at April 30, 2023, During the nine April 30, 2023, Subsequent to April 30, 2023, May 20 June 2, 2023 Stock Options As of April 30, 2023, one 2022 “2022 2021 no 2021 A continuity schedule of our outstanding stock options for the three nine April 30, 2023, Number of Stock Weighted Average Balance, July 31, 2022 8,880,527 $ 1.58 Issuance of Replacement Options (Note 3) 2,301,750 1.90 Granted 5,000 4.23 Exercised (2,331,222 ) 1.61 Balance, October 31, 2022 8,856,055 1.65 Granted 15,464 3.78 Exercised (197,110 ) 2.10 Balance, January 31, 2023 8,674,409 1.65 Granted 100,000 3.22 Exercised (337,500 ) 1.61 Balance, April 30, 2023 8,436,909 $ 1.67 The table below sets forth the number of shares issued and cash received upon exercise of our stock options: Three Months Ended April 30, Nine Months Ended April 30, 2023 2022 2023 2022 Number of Options Exercised on Cash Basis - 404,832 138,537 807,580 Number of Options Exercised on Forfeiture Basis 337,500 777,773 2,727,295 1,650,402 Total Number of Options Exercised 337,500 1,182,605 2,865,832 2,457,982 Number of Shares Issued on Cash Exercise - 404,832 138,537 807,580 Number of Shares Issued on Forfeiture Basis 204,693 595,478 1,565,059 1,140,065 Total Number of Shares Issued Upon Exercise of Options 204,693 1,000,310 1,703,596 1,947,645 Cash Received from Exercise of Stock Options $ - $ 404 $ 206 $ 851 Total Intrinsic Value of Options Exercised $ 858 $ 4,891 $ 6,834 $ 7,685 A continuity schedule of our outstanding unvested stock options as of April 30, 2023, Number of Unvested Weighted Average Grant-Date Fair Value Balance, July 31, 2022 2,186,154 $ 1.79 Issuance of Replacement Options (Note 3) 2,301,750 1.75 Granted 5,000 2.70 Vested (2,467,341 ) 1.79 Balance, October 31, 2022 2,025,563 1.74 Granted 15,464 2.40 Vested (394,858 ) 1.78 Balance, January 31, 2023 1,646,169 $ 1.74 Granted 100,000 2.04 Vested (15,680 ) 1.56 Balance, April 30, 2023 1,730,489 $ 1.76 As at April 30, 2023, April 30, 2023, A summary of our stock options outstanding and exercisable as of April 30, 2023, Options Outstanding Options Exercisable Range of Exercise Outstanding at Weighted Weighted Exercisable at April 30, 2023 Weighted Weighted $0.80 to $0.99 3,592,124 $ 0.92 6.78 3,592,124 $ 0.92 6.78 $1.00 to $1.99 2,442,500 1.29 4.12 2,000,832 1.33 3.44 $2.00 to $2.99 918,954 2.22 7.96 687,183 2.22 7.87 $3.00 to $3.99 1,478,331 3.76 8.37 425,031 3.78 7.61 $4.00 to $4.23 5,000 4.23 9.49 1,250 4.23 9.49 8,436,909 $ 1.67 6.42 6,706,420 $ 1.36 5.95 Restricted Stock Units A summary of our outstanding and unvested restricted stock units (“RSU”s) as of April 30, 2023, Grant Date Number of Grant Date Remaining Life Aggregate July 16, 2020 217,498 $ 0.91 0.21 $ 568 July 21, 2021 271,746 2.15 1.23 709 May 01, 2022 58,824 4.25 2.01 154 July 29, 2022 287,966 3.98 2.25 752 836,034 $ 2.61 1.37 $ 2,183 During the three nine April 30, 2023, three nine April 30, 2022: April 30, 2023, Performance Based Restricted Stock Units During the three nine April 30, 2023, three nine April 30, 2022: April 30, 2023, July 31, 2022: July 31, 2022: Stock-Based Compensation A summary of our stock-based compensation expense is as follows: Three Months Ended April 30, Nine Months Ended April 30, 2023 2022 2023 2022 Stock-Based Compensation for Consultants Common stock issued to consultants $ 107 $ 158 $ 382 $ 664 Amortization of stock option expenses 95 37 467 174 202 195 849 838 Stock-Based Compensation for Management Amortization of stock option expenses 95 91 323 382 Amortization of RSU and PRSU expenses 346 256 1,053 780 441 347 1,376 1,162 Stock-Based Compensation for Employees Common stock issued to employees 188 282 675 894 Amortization of stock option expenses 314 127 1,441 632 Amortization of RSU expenses 37 - 114 - 539 409 2,230 1,526 $ 1,182 $ 951 $ 4,455 $ 3,526 |